paroxetine has been researched along with Fatigue in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 12 (66.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Boldt, G; Bruera, E; Chiu, L; Chow, R; Lock, M; Prsic, E; Sanatani, M | 1 |
| Alfano, CM; Heckler, C; Kleckner, AS; Kleckner, IR; Leach, CR; Miller, SM; Mohr, D; Mustian, KM; Palesh, OG; Peppone, LJ; Piper, BF; Scarpato, J; Smith, T; Sprod, LK | 1 |
| Hotopf, M; Minton, O; Richardson, A; Sharpe, M; Stone, P | 1 |
| Palshof, T; Pedersen, L | 1 |
| Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
| Angus, M; Crawford, GM; Hamilton, L; Wade, A; Wilson, R | 1 |
| Andrews, PL; Banerjee, TK; Flynn, PJ; Hickok, JT; Hynes, HE; King, DK; Kirshner, JJ; Morrow, GR; Raubertas, RF; Roscoe, JA | 1 |
| Brown, EB; Joliat, MJ; Miner, CM | 1 |
| Bushunow, P; Griggs, JJ; Hickok, JT; Matteson, SE; Morrow, GR; Mustian, KM; Qazi, R; Roscoe, JA; Smith, B | 1 |
| Arora, S; DeBattista, C; Fava, M; Hughes, RJ; Thase, ME | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Debattista, C; Schatzberg, AF | 1 |
| Donike, M; Gotzmann, A; Hollmann, W; Platen, P; Strüder, HK; Weber, K | 1 |
| Strüder, HK; Weicker, H | 1 |
| McNeil, C | 1 |
| Jacobsen, PB; Minton, S; Moncello, J; Weitzner, MA | 1 |
| Maughan, RJ; Wilson, WM | 1 |
4 review(s) available for paroxetine and Fatigue
| Article | Year |
|---|---|
Cancer-related fatigue-pharmacological interventions: systematic review and network meta-analysis.
Topics: Central Nervous System Stimulants; Fatigue; Humans; Methylphenidate; Modafinil; Neoplasms; Network Meta-Analysis; Paroxetine | 2023 |
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Exercise Therapy; Fatigue; Glucocorticoids; Humans; Methylphenidate; Methylprednisolone; Modafinil; Neoplasms; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Wakefulness-Promoting Agents | 2017 |
A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.
Topics: Anemia; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Central Nervous System Stimulants; Darbepoetin alfa; Dopamine Uptake Inhibitors; Erythropoietin; Fatigue; Hematinics; Humans; Methylphenidate; Neoplasms; Odds Ratio; Paroxetine; Progestins; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
[Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review].
Topics: Antidepressive Agents, Second-Generation; Central Nervous System Stimulants; Erythropoietin; Evidence-Based Medicine; Fatigue; Hematinics; Humans; Methylphenidate; Neoplasms; Paroxetine; Progestins; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
8 trial(s) available for paroxetine and Fatigue
| Article | Year |
|---|---|
A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Fatigue; Female; Headache; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Paroxetine; Primary Health Care; Severity of Illness Index; Sweating; Treatment Outcome | 2003 |
Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Depression; Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Neoplasms; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Breast Neoplasms; Depression; Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Treatment Outcome | 2005 |
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Disorders of Excessive Somnolence; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fatigue; Female; Humans; Male; Middle Aged; Modafinil; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans.
Topics: Adult; Amino Acids, Branched-Chain; Exercise Test; Fatigue; Humans; Male; Neurosecretory Systems; Paroxetine; Psychometrics; Selective Serotonin Reuptake Inhibitors; Tyrosine | 1998 |
A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Depression; Fatigue; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders | 2002 |
Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise.
Topics: Adult; Exercise Test; Fatigue; Humans; Male; Middle Aged; Oxygen Consumption; Paroxetine; Physical Endurance; Serotonin; Serotonin Antagonists; Time Factors | 1992 |
6 other study(ies) available for paroxetine and Fatigue
| Article | Year |
|---|---|
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Are SSRIs safe for children?
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Depression; Fatigue; Humans; Nausea; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders | 2003 |
Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.
Topics: Citalopram; Depressive Disorder; Drug Administration Schedule; Fatigue; Fluoxetine; Humans; Paroxetine; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Physical symptoms associated with paroxetine withdrawal.
Topics: Adult; Depressive Disorder; Dizziness; Ejaculation; Fatigue; Humans; Male; Middle Aged; Nausea; Paroxetine; Substance Withdrawal Syndrome; Tremor | 1995 |
Influence of exercise on serotonergic neuromodulation in the brain.
Topics: Adult; Amino Acids, Branched-Chain; Binding Sites; Blood Platelets; Brain; Cell Nucleus; Dose-Response Relationship, Drug; Exercise; Fatigue; Humans; Male; Models, Biological; Neurons; Paroxetine; Prolactin; Protein Binding; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction | 2001 |
Cancer fatigue: one drug fails but more are in the pipeline.
Topics: Clinical Trials as Topic; Depression; Dexamethasone; Fatigue; Humans; Neoplasms; Paroxetine; Prednisolone; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 2001 |